Research To Practice | Oncology Videos
Podcast image
Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas
133 hours 33 mins; April 02, 2026
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
24 mins; April 01, 2026
AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
89 hours 23 mins; March 30, 2026
Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
75 hours 32 mins; March 28, 2026
Metastatic Bladder Cancer — Rapid Case Review Issue 3
32 mins; March 27, 2026
Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
17 mins; March 26, 2026
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
118 hours 7 mins; March 25, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
24 mins; March 24, 2026
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
24 mins; March 23, 2026
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
29 mins; March 21, 2026
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
21 mins; March 19, 2026
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
30 mins; March 18, 2026
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
16 mins; March 16, 2026
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
12 mins; March 14, 2026
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
63 hours 21 mins; March 13, 2026
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah (Companion Faculty Lecture)
48 mins; March 12, 2026
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
47 mins; March 11, 2026
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting (Companion Faculty Lecture)
38 mins; March 10, 2026
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
19 mins; March 09, 2026
Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
55 mins; March 07, 2026
Ovarian Cancer | Nicoletta Colombo, MD
24 mins; March 06, 2026
Ovarian Cancer | Angeles Alvarez Secord, MD, MHSc
29 mins; March 06, 2026
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
59 mins; March 06, 2026
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
24 mins; March 03, 2026
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
58 mins; March 02, 2026
Antibody-Drug Conjugates for Breast Cancer | Sara M Tolaney, MD, MPH
25 mins; March 01, 2026
Antibody-Drug Conjugates for Breast Cancer | Hope S Rugo, MD
49 mins; February 28, 2026
Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
59 mins; February 27, 2026
Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
120 hours 24 mins; February 26, 2026
Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
23 mins; February 23, 2026
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
57 mins; February 18, 2026
Metastatic Bladder Cancer — Rapid Case Review Issue 2
29 mins; February 17, 2026
Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
57 mins; February 16, 2026
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
17 mins; February 13, 2026
Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih
37 mins; February 12, 2026
Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih (Companion Faculty Lecture)
37 mins; February 11, 2026
Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 Review
18 mins; February 10, 2026
Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore
54 mins; February 09, 2026
Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore (Companion Faculty Lecture)
36 mins; February 09, 2026
Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
91 hours 15 mins; February 07, 2026
Immune Thrombocytopenia — ASH 2025 Review
90 hours 7 mins; February 06, 2026
Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review
31 mins; February 04, 2026
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
23 mins; February 03, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
117 hours 8 mins; February 02, 2026
Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 Review
18 mins; January 29, 2026
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium
88 hours 41 mins; January 28, 2026
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
121 hours 8 mins; January 27, 2026
Metastatic Bladder Cancer — Rapid Case Review Issue 1
27 mins; January 23, 2026
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
61 hours 13 mins; January 21, 2026
Relapsed/Refractory Multiple Myeloma — ASH 2025 Review
61 hours 6 mins; January 17, 2026
HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
118 hours 19 mins; January 14, 2026
Follicular Lymphoma and Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
116 hours 55 mins; January 13, 2026
Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
23 mins; January 12, 2026
Myelofibrosis and Systemic Mastocytosis — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
117 hours 30 mins; January 09, 2026
Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
90 hours 22 mins; January 08, 2026
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
115 hours 47 mins; January 07, 2026
Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
20 mins; January 06, 2026
Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
117 hours 33 mins; January 03, 2026
Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases
60 hours 14 mins; December 23, 2025
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
60 hours 36 mins; December 22, 2025
Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual Meeting
61 hours 32 mins; December 19, 2025
Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
57 mins; December 17, 2025
Gastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology Network
50 mins; December 13, 2025
Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
48 mins; December 13, 2025
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
51 mins; December 12, 2025
Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
103 hours 11 mins; December 12, 2025
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
58 mins; December 11, 2025
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
65 hours 14 mins; December 10, 2025
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach (Companion Faculty Lecture)
26 mins; December 09, 2025
Breast Cancer — Highlights from the 2025 ESMO Annual Meeting
87 hours 40 mins; December 08, 2025
Breast Cancer — Microlearning Activity 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
13 mins; December 05, 2025
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
52 mins; December 04, 2025
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning (Companion Faculty Lecture)
34 mins; December 03, 2025
Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
14 mins; December 02, 2025
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
58 mins; November 29, 2025
Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
11 mins; November 26, 2025
HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases
57 mins; November 21, 2025
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
58 mins; November 20, 2025
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders (Companion Faculty Lecture)
29 mins; November 19, 2025
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
59 mins; November 15, 2025
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
150 hours 36 mins; November 14, 2025
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
60 hours 13 mins; November 13, 2025
Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
64 hours 26 mins; November 12, 2025
Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
54 mins; November 11, 2025
Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
117 hours 52 mins; November 10, 2025
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
21 mins; November 07, 2025
Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
60 hours 18 mins; November 06, 2025
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders
41 mins; November 05, 2025
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders (Companion Faculty Lecture)
42 mins; November 03, 2025
Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis
50 mins; October 30, 2025
Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis (Companion Faculty Lecture)
31 mins; October 29, 2025
Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
15 mins; October 24, 2025
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
54 mins; October 23, 2025
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA (Companion Faculty Lecture)
34 mins; October 22, 2025
Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates
56 mins; October 21, 2025
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
24 mins; October 20, 2025
Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management
57 mins; October 18, 2025
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
43 mins; October 14, 2025
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment (Companion Faculty Lecture)
31 mins; October 13, 2025
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
59 mins; October 10, 2025